Using shock wave therapy to treat lower limb lymphedema
Official title: Lower Limb Lymphedema Treatment by Extracorporeal Shock Wave Therapy: Clinical Trial
Run by Parc de Salut Mar · NCT06454734 · Data updated 2026-11-12
This study is testing if adding shock wave therapy to regular treatments can help people with lower limb lymphedema feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Parc de Salut Mar Academic / other |
| Locations | 1 site (Barcelona) |
| Status | Recruiting |
| Started | May 28, 2024 |
| Main results expected | July 2026 |
| Study ends | December 2026 |
| Registry record updated | July 31, 2025 |
| Trial ID | NCT06454734 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with moderate to severe lower limb lymphedema lasting at least 6 months.
✕Probably not a fit
Patients with coagulation disorders, recent deep vein thrombosis, or those unable to walk independently may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of shock wave therapy combined with complex decongestive therapy for patients suffering from lower limb lymphedema. It involves a double-blind, randomized design with two groups: one receiving the active shock wave therapy and the other receiving a placebo. Both groups will undergo standard treatments including manual lymphatic drainage and compression, with a total of 10 sessions over 5 weeks. The study aims to assess the impact of shock wave therapy on lymphedema symptoms and overall patient outcomes.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the management of lower limb lymphedema, enhancing patients' quality of life.
How similar studies have gone: While the use of shock wave therapy is a novel approach in this context, similar studies have shown promise in other conditions, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria * Patients with lower limb lymphedema * Lymphedema of at least 6 months of evolution * The lymphedema must affect at least the knee to the foot * Moderate or severe lymphedema (grades 2 or 3) * Sign the informed consent Exclusion criteria * Under 18 years of age * Coagulation disorders (hemophilia, treatment with acenocoumarol, etc.) * Current or previous deep vein thrombosis of the lower extremity * Pregnancy * Electronic implantable medical devices as pacemaker implants, medication pumps, etc * Having received treatment with complex decongestive therapy or shock waves during the last 6 months * Treatment with corticosteroids or radiotherapy in the area to be treated in the last 6 weeks * Active oncological disease in the area to be treated * Active infectious-inflammatory process in the area to be treated * Cognitive or sensory deficits that prevent collaboration * Inability to walk independently or inability to attend therapy
Where it's running
-
Hospital del Mar
Barcelona, Spain Recruiting
Study contacts
- Principal investigator: Roser Belmonte, MD, PhD — Hospital del Mar
- Study coordinator: Roser Belmonte, MD, PhD
- Email: rbelmonte@psmar.cat
- Phone: +34 933674214
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Extracorporeal Shock Wave Therapy to Help Lower-Limb Lymphedema (with standard CDT)
This trial tests whether adding extracorporeal shock wave therapy to standard decongestive therapy helps people with lower-limb lymphedema.
-
Comparing lymphaticovenous anastomosis to sham surgery for cancer-related lymphedema
This study is testing if a new surgery for cancer-related lymphedema can help people feel better compared to a fake surgery.
-
Sexual behavior and STI risk perception in young adults in Barcelona
Young adults in Barcelona will complete anonymous questionnaires to see how their sexual behavior and beliefs about STI risk relate to self-reported STI occurrences.
-
Extended follow-up of people who went to emergency care after a suicide attempt in Spain
This project will follow people seen in Spanish emergency departments after a suicide attempt to see if personal, social, biological factors and different follow-up approaches affect the chance of trying again.
-
Spanish SPQUSS-41 questionnaire to measure quality of life after stomach cancer surgery
We will test whether the Spanish SPQUSS-41 questionnaire accurately measures quality of life in adults who had curative stomach cancer surgery.
-
PEARL: Rehabilitation and recovery after atrial fibrillation-related ischemic stroke
This project will see if adults with atrial fibrillation-related ischemic stroke have different rehabilitation needs and whether higher-intensity inpatient therapy (3–5 sessions/day) leads to better functional recovery at six months than moderate-intensity care (1 session/day).
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.